E613-0674 Screening compound: N-[3-(2-chlorophenyl)-1,2-oxazol-5-yl]-2-{[5-(4-fluorophenyl)-1,2-oxazol-3-yl]methoxy}acetamide

E613-0674 Screening compound: N-[3-(2-chlorophenyl)-1,2-oxazol-5-yl]-2-{[5-(4-fluorophenyl)-1,2-oxazol-3-yl]methoxy}acetamide
E613-0674 Screening compound: N-[3-(2-chlorophenyl)-1,2-oxazol-5-yl]-2-{[5-(4-fluorophenyl)-1,2-oxazol-3-yl]methoxy}acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound E613-0674
N-[3-(2-chlorophenyl)-1,2-oxazol-5-yl]-2-{[5-(4-fluorophenyl)-1,2-oxazol-3-yl]methoxy}acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E613-0674

Molecular Formula

C21H15ClFN3O4 (C21 H15 ClFN3 O4)

Compound Name

N-[3-(2-chlorophenyl)-1,2-oxazol-5-yl]-2-{[5-(4-fluorophenyl)-1,2-oxazol-3-yl]methoxy}acetamide

IUPAC name

N-[3-(2-chlorophenyl)-12-oxazol-5-yl]-2-{[5-(4-fluorophenyl)-12-oxazol-3-yl]methoxy}acetamide

SMILES

O=C(COCc1noc(-c(cc2)ccc2F)c1)Nc1cc(-c(cccc2)c2Cl)no1

InChI

InChI=1S/C21H15ClFN3O4/c22-17-4-2-1-3-16(17)18-10-21(30-26-18)24-20(27)12-28-11-15-9-19(29-25-15)13-5-7-14(23)8-6-13/h1-10H,11-12H2,(H,24,27)

InChI Key

VOOSMKCTOOVKDS-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14904135

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

427.82

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.489

Distribution Coefficient, logD

4.486

Water Solubility, LogSw

-4.52

Polar Surface Area

75.862

Acid Dissociation Constant (pKa)

9.46

Base Dissociation Constant (pKb)

-3.11

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

9.50

E613-0674 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GABA Library (7115 compounds)

KRAS-Targeted Library (16000 compounds)

Protein-Protein Interaction Library (218420 compounds)

Aurora A-B Kinases Targeted Library (9426 compounds)

Chemokine Receptor-Targeted Library (18382 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Eye
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Cancer
  • Digestive system
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
Targets:
  • GPCR
  • Ion Channels
  • Kinases
  • Kinases
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • Receptor's ligands

References: we are preparing a list of scientific research reports with E613-0674 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E613-0674?
Check Price and Availability of E613-0674, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E613-0674 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E613-0674
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E613-0674
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E613-0674 available by request